Mechanistically, KIF4A likely drives ccRCC progression through two main pathways: regulating the cell cycle and remodelling the tumour immune microenvironment, establishing it as a potential prognostic biomarker associated with immune infiltration [95, 98]. Here, KIF4A is linked to neoplasm.